End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF).
End-stage renal disease (ESRD) is a debilitating, costly, and increasingly common condition. Little is known about how different financing approaches affect ESRD outcomes and delivery of care. This paper presents results from a comparative review of 12 countries with alternative models of incentives and benefits, collected under the International Study of Health Care Organization and Financing, a substudy within the Dialysis Outcomes and Practice Patterns Study. Variation in spending per ESRD patient is relatively small, but correlated with overall per capita health care spending. Remaining differences in costs and outcomes do not seem strongly linked to differences in incentives.
Dor
Avi
A
George Washington University, School of Public Health and Health Services, Washington, DC, USA. avidor@gwu.edu
Pauly
Mark V
MV
Eichleay
Margaret A
MA
Held
Philip J
PJ
D000368:Aged; D003956:Dialysis / Q000191:economics*; D004470:Economics, Medical; D005260:Female; D017048:Health Care Costs; D005102:Health Expenditures; D006801:Humans; D015994:Incidence; D007676:Kidney Failure, Chronic / Q000191:economics* / Q000453:epidemiology / Q000628:therapy*; D016030:Kidney Transplantation / Q000191:economics; D008297:Male; D008875:Middle Aged; D017059:Models, Econometric; D009313:National Health Programs / Q000458:organization & administration; D015995:Prevalence; D011787:Quality of Health Care / Q000458:organization & administration; D012051:Reimbursement Mechanisms / Q000458:organization & administration; D016896:Treatment Outcome